The effect of anti-helicobacter pylori with iron folate supplementation and only iron folate supplementation of helicobacter pylori infected CagA positive Indian non-pregnant women

Bandana Sen

doi:10.18203/2394-6040.ijcmph20251381

Authors

Bandana Sen Health Research and Training Institute, Society for Applied Studies, Kolkata, West Bengal, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20251381

Keywords:

Anemia, Anti H. pylori therapy, CagA, Helicobacter pylori, Iron folate supplementation

Abstract

Background: Helicobacter pylori is a type of bacteria that infects our stomach and small intestine. This study aimed to evaluate response to H. pylori infection of the anti H. pylori therapy with iron folate supplementation and only iron folate supplementation of CagA positive and CagA negative women.

Methods: The non-pregnant Indian women (18-35 years) whose Hemoglobin<115 gm/dl, body mass index<20 kg/m2 and H. pylori positive status were recruited in our study. H. pylori positive strains women were divided two groups CagA positive and CagA negative. Depending on types of supplementations, both CagA positive and CagA negative women were divided by two groups treatment and Control. Treatment group received 7 days anti H. pylori therapy then 3 months iron folate supplementation. Control group received only iron folate supplementation for 3 months.

Results: Total 81 women were H. pylori infected and among them 65 (80.2%) were CagA positive and 16 (19.8%) were CagA negative. There were no significant correlations of hematological parameters between H. pylori infected CagA positive and CagA negative women. At baseline Hb, MCV, MCH and TIBC value was comparatively lower of CagA positive than CagA negative women. After 3 months intervention Hb, MCV and Ferritin were increased significantly (p<0.05) higher in treatment group than control group of CagA positive women.

Conclusions: After 3 months supplementation of anti H. pylori therapy with iron folate supplementation of CagA positive strains was better response than CagA negative strains of child bearing aged non pregnant women.

Metrics

Metrics Loading ...

References

Mitchell H, Katelaris P. Epidemiology, clinical impacts and current clinical management of H. pylori infection. Med J Aust. 2016;204(10):376-80. DOI: https://doi.org/10.5694/mja16.00104

https://www.hopkinsmedicine.org/health/helicobacter.

Warren JR, Marshall B. Unidentified Curved Bacilli on Gastric Epithelium in Active Chronic Gastritis. Lancet 1983; 1(8336):1273-5. DOI: https://doi.org/10.1016/S0140-6736(83)92719-8

Zamani M, Ebrahimtabar F, Zamani V, Miller WH, Alizadeh-Navaei R, Shokri- Shirvani J, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther 2018; 47(7):868-76. DOI: https://doi.org/10.1111/apt.14561

Kamboj AK, Cotter TG, Oxentenko AS. Helicobacter pylori: The past, present and future in management. Mayo Clin Proc. 2017;92(4):599-604. DOI: https://doi.org/10.1016/j.mayocp.2016.11.017

Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, et al. Major virulence factors, VacA and CagA are commonly positive in Helicobacter Pylori isolates in Japan. Gut. 1998;42(3):338-43. DOI: https://doi.org/10.1136/gut.42.3.338

Stein M, Ruggiero P, Rappuoli R, Bagnoli F. Helicobacter Pylori CagA: From pathogenic mechanisms to its use as an anti-cancer vaccine. Front Immunol. 2013;4:328. DOI: https://doi.org/10.3389/fimmu.2013.00328

Blum AL. Helicobacter pylori and peptic ulcer disease. Scand J Gastroenterol 1996;214:24-7. DOI: https://doi.org/10.3109/00365529609094511

Censini S, Lange C, Xiang Z, Crabtree JE, Ghiara P, Borodovsky M, et al. Cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci. 1996;93(25):14648–53. DOI: https://doi.org/10.1073/pnas.93.25.14648

Bourzac KM, Guillemin K. Helicobacter pylori-host cell interactions mediated by type IV secretion. Cell Microbiol. 2005;7:911–9. DOI: https://doi.org/10.1111/j.1462-5822.2005.00541.x

Ekström AM, Held M, Hansson LE, Engstrand L, Nyrén O. Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterol. 200;121(4):784–91. DOI: https://doi.org/10.1053/gast.2001.27999

Moradi MT, Salehi Z, Asl SF, Aminian K, Hashtchin AR. Helicobacter pylori Infection and MDM2 SNP309 association with Gastric Cancer Susceptibility. Genet Test and Mol Biomarkers. 2013;17(11):794-8. DOI: https://doi.org/10.1089/gtmb.2013.0173

Saruc M, Goksel G, Ozkaya S, Guclu F, Ozbakkaloglu B, Yuceyar H. The effect of CagA status on response to Helicobacter Pylori eradication therapy in Western Turkey. Braz J Med Biol Res. 2001; 34(11):1435-9. DOI: https://doi.org/10.1590/S0100-879X2001001100010

Pourfarzi F, Whelan A, Kaldor J, Malekzadeh R. The role of diet and other environmental factors in the causation of gastric cancer in Iran--a population based study. Int J Cancer. 2009;125(8):1953-60. DOI: https://doi.org/10.1002/ijc.24499

Broutet N, Marais A, Liu D, Lamouliatte H, Samoyeau R, Megraud F. CagA negative status: a risk factor for failure of Helicobacter pylori triple therapies in non-ulcer dyspepsia. Gut. 1998;43:79. DOI: https://doi.org/10.1016/S0016-5085(98)80870-6

Hulst RW, Ende A, Dekker FW, Ten Kate FJ, Weel JF, Keller JJ, et al. Effect of Helicobacter pylori eradication on gastritis in relation to CagA: a prospective 1-year follow-up study. Gastroenterol. 1997;113(1):25-30. DOI: https://doi.org/10.1016/S0016-5085(97)70076-3

Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG and de Boer WA. Importance of Helicobacter pylori CagA and VacA status for the efficacy of antibiotic treatment. Gut. 2000;46(3):321-6. DOI: https://doi.org/10.1136/gut.46.3.321

Park JY, Forman D, Waskito LA, Yamaoka Y, Crabtree JE. Epidemiology of Helicobacter pylori and CagA- Positive infection and global variations in Gastric Cancer. Toxins. 2018;10(4):163. DOI: https://doi.org/10.3390/toxins10040163

Mahalanabis D, Islam MA, Shaikh S, Chakrabarty M, Kurpad AV, Mukharjee S, et al. Hamatological response to iron supplementation is reduced in children with asymptomatic Helicobacter pylori infection. Br J Nutr. 2005;94(6):969-75. DOI: https://doi.org/10.1079/BJN20051586

Kitila KT, Sori LM, Desalegn DM, Tullu KD. Burden of Helicobacter Pylori infections and associated risk factors among women of child bearing age in Addis Ababa, Ethiopia. Int J Chronic Dis. 2018;12:5183713. DOI: https://doi.org/10.1155/2018/5183713

Amieva M, Peek Jr RM. Pathobiology of Helicobacter pylori-induced gastric cancer. Gastroenterol. 2016;150(1): 64–78. DOI: https://doi.org/10.1053/j.gastro.2015.09.004

Weisy OKM, Kedia RA, Mahmoud I, Odeh ROA, Mussa BM, Abusnana S, et al. Assessment of Helicobacter Pylori cytotoxin – associated Gene A (Cag A) protein and its association with ferritin and vitamin B12 and deficiencies among adult healthy asymptomatic residents in Sharjah, United Arab Emirates. Heliyon. 2024;10(11):332141. DOI: https://doi.org/10.1016/j.heliyon.2024.e32141

Mubaraki MA, Alalhareth AS, Aldawood E, Albouloshi A, Aljarah MS, Hafiz TA, et al. The iron deficiency anemia in association to Helicobacter pylori infection in Najran city, Saudi Arabia. J King Saud Univ Sci. 2022; 34(8):102353. DOI: https://doi.org/10.1016/j.jksus.2022.102353

Saju JM, Mandal N, Kham NI, Shahid R, Naik SS, Ramphall S, et al. Is Helicobacter Pylori a reason for unexplained iron deficiency anemia: A systematic Review. Cureus .2022;14(9):29112.

Lee JY, Kim SE, Park SJ, Park MI, Moon W, Kim JH, et al. Helicobacter pylori infection and iron deficiency in non-elderly adults participating in a health check-up program. Korean J Intern Med. 2022;37(2):304–12. DOI: https://doi.org/10.3904/kjim.2020.433

John S, Baltodano JD, Mehta N, Mark K, Murthy U. Unexplained iron deficiency anemia: does Helicobacter pylori have a role to play. Gastroenterol Rep. 2018;6(3):215–20. DOI: https://doi.org/10.1093/gastro/goy001

Hou B, Zhang M, Liu M, Dai W, Lin Y, Li Y, et al. Association of active Helicobacter pylori infection and anemia in elderly males. BMC Infect Dis. 2019;19(1):228. DOI: https://doi.org/10.1186/s12879-019-3849-y

Tan S, Tompkins LS, Amieva MR. Helicobacter pylori usurps cell polarity to turn the cell surface into a replicative niche. PLos Pathog. 2009;5(5):1000407. DOI: https://doi.org/10.1371/journal.ppat.1000407

Flores SE, Aitchison A, Day AS, Keenan JI. Helicobacter pylori infection perturbs iron homeostasis in gastric epithelial cells. Plos One. 2017;12(9):184026. DOI: https://doi.org/10.1371/journal.pone.0184026

Malik R, Guleria K, Kaur I, Sikka M, Radhakrishnan G. Effect of Helicobacter Pylori eradication therapy in iron deficiency anemia of Pregnancy- A pilot study. Indian J Med Res. 2011;134(2): 224-31.

Sharif N, Das B, Alam A. Prevalence of anemia among reproductive women in different social group in India: Cross sectional study using nationally reproductive data. Plos One. 2023;18(2):281015. DOI: https://doi.org/10.1371/journal.pone.0281015